- Home
- APLT vs AWF Comparison
APLT vs AWF Comparison
Compare APLT & AWF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLT
- AWF
- Stock Information
- Founded
- APLT 2016
- AWF 1993
- Country
- APLT United States
- AWF United States
- Employees
- APLT N/A
- AWF N/A
- Industry
- APLT Biotechnology: Pharmaceutical Preparations
- AWF Trusts Except Educational Religious and Charitable
- Sector
- APLT Health Care
- AWF Finance
- Exchange
- APLT Nasdaq
- AWF Nasdaq
- Market Cap
- APLT 52.9M
- AWF 928.7M
- IPO Year
- APLT 2019
- AWF N/A
- Fundamental
- Price
- APLT $0.33
- AWF $11.10
- Analyst Decision
- APLT Buy
- AWF
- Analyst Count
- APLT 7
- AWF 0
- Target Price
- APLT $6.10
- AWF N/A
- AVG Volume (30 Days)
- APLT 2.3M
- AWF 190.0K
- Earning Date
- APLT 08-06-2025
- AWF 01-01-0001
- Dividend Yield
- APLT N/A
- AWF 7.57%
- EPS Growth
- APLT N/A
- AWF N/A
- EPS
- APLT N/A
- AWF N/A
- Revenue
- APLT $265,000.00
- AWF N/A
- Revenue This Year
- APLT $1,768.13
- AWF N/A
- Revenue Next Year
- APLT $292.85
- AWF N/A
- P/E Ratio
- APLT N/A
- AWF N/A
- Revenue Growth
- APLT N/A
- AWF N/A
- 52 Week Low
- APLT $0.30
- AWF $9.20
- 52 Week High
- APLT $10.62
- AWF $10.67
- Technical
- Relative Strength Index (RSI)
- APLT 43.25
- AWF 72.22
- Support Level
- APLT $0.30
- AWF $10.98
- Resistance Level
- APLT $0.36
- AWF $11.15
- Average True Range (ATR)
- APLT 0.03
- AWF 0.06
- MACD
- APLT -0.00
- AWF 0.02
- Stochastic Oscillator
- APLT 22.22
- AWF 87.18
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
About AWF Alliancebernstein Global High Income Fund
Alliancebernstein Glb High Inc Fund Inc is a United States-based diversified, closed-end management investment company. Its primary investment objective is to seek high current income, and secondarily, capital appreciation. The fund invests in debt securities, including Sovereign Debt Obligations and corporate debt, denominated in non-U.S. currencies as well as in the U.S. Dollar. It may invest without limit in emerging and developed markets and debt securities of U.S. and non-U.S. corporate issuers.